Chaperone-rich cell lysates, immune activation and tumor vaccination
/in Dendritic Cells, Hyperthermia, International Publications /von 2005-05-11 / Cancer Immunol. Immunother. 2006 Mar;55(3):329-38[Induction of apoptosis in human hepatoma cell line SMMC7721 by Newcastle disease virus HN gene]
/in International Publications, Newcastle Disease Virus /von 2005-05-01 / Zhonghua Zhong Liu Za Zhi 2005 May;27(5):279-82Randomized trial of hyperthermia and radiation for superficial tumors
/in Breast Cancer, Hyperthermia, International Publications, Malignant Melanoma /von 2005-05-01 / J. Clin. Oncol. 2005 May;23(13):3079-85Tumor-dendritic cell fusion as a basis for cancer immunotherapy
/in International Publications, NSCLC /von 2005-05-01 / Otolaryngol Head Neck Surg 2005 May;132(5):755-64Editorial: clinical hyperthermia combined with radiation is safe
/in Cervical Cancer, International Publications /von 2005-05-01 / Int J Hyperthermia 2005 May;21(3):193-7Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models
/in Hepatocellular Carcinoma, International Publications /von 2005-05-01 / Int. J. Oncol. 2005 May;26(5):1313-9Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function
/in Dendritic Cells, Hyperthermia, International Publications /von 2005-04-28 / Cancer Immunol. Immunother. 2006 Mar;55(3):292-8Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
/in Colorectal Cancer, International Publications /von 2005-04-15 / Clin. Cancer Res. 2005 Apr;11(8):3017-24Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity
/in Dendritic Cells, International Publications /von 2005-04-04 / J. Leukoc. Biol. 2005 Aug;78(2):319-24
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de